Clinical trials - Press Releases

Date	Title	Company
19-Apr-2022	PHASTAR Names Ping-Chung Chang as Head of China Development and Global Delivery	PHASTAR
19-Apr-2022	Clinerion adds Patient Network Explorer coverage to three new hospitals in Brazil, bringing the Brazilian total to 22 hospitals and over 8 million patients.	Clinerion Ltd.
19-Apr-2022	Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 - Best Contract Research Organization in APAC	Avance Clinical
12-Apr-2022	Omnix Medical Starts Phase I Clinical Trial of Novel Anti-Infective; First Healthy Volunteers Dosed	Omnix Medical
11-Apr-2022	CluePoints Wins Citeline Award for Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities	CluePoints
07-Apr-2022	AZD8233 reduced low-density lipoprotein cholesterol levels by 73% in patients with high-risk hypercholesterolemia in ETESIAN Phase IIb trial	AstraZeneca
07-Apr-2022	Celsion and Medidata to Present Findings on Use of Synthetic Control Arm to Estimate Treatment Effect in Ovarian Cancer Trial	Celsion
06-Apr-2022	FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA	SMi Group
06-Apr-2022	Early access issued for eligible patients in the UK for radioligand therapy in advanced prostate cancer	Advanced Accelerator Applications (AAA), a Novartis company.
05-Apr-2022	Achilles Therapeutics to Host KOL Webcast to Highlight TRACERx Study Presentations from the 2022 AACR Annual Meeting	Achilles Therapeutics
05-Apr-2022	DIAMOND trial: Veltassa® enables patients to achieve long-term potassium control and optimized RAASi therapy	Vifor Pharma
05-Apr-2022	FDA accepts Dupixent® (dupilumab) for Priority Review in patients aged 12 years and older with eosinophilic esophagitis	Regeneron
05-Apr-2022	AI test could predict effective cancer drug combinations in less than two days	ICR
05-Apr-2022	Beckley Psytech announces dosing of first healthy volunteers in Phase 1 clinical trial assessing safety and pharmacokinetics of second innovative formulation of 5-MeO-DMT	Beckley Psytech
05-Apr-2022	FDA Grants Permission to Enroll up to 8 Additional Secondary Progressive Multiple Sclerosis (SPMS) Patients in the Expanded Access Program with Intranasal Foralumab	FDA
05-Apr-2022	CluePoints Continues Impressive Global Growth with Three New Senior Appointments	CluePoints
05-Apr-2022	Almac Group Clinical Supply And Commercial Solutions Support Agios' Road To FDA Approval	Almac Group
05-Apr-2022	AXON hires a Global Healthcare Insights and Strategy Lead	AXON
31-Mar-2022	Avance Clinical Announces New Office Opening in Melbourne	Avance Clinical
31-Mar-2022	TILT Biotherapeutics Announces Positive Update on its Phase 1 Immunotherapy Clinical Trials in Cancer	TILT Biotherapeutics